Podcast 11 Apr 2025
How nanobodies will revolutionize immunotherapy
From llamas and camels to humans worldwide – learn about nanobodies in our talk with Kristian Reich, co-founder of MoonLake Immunotherapeutics.
- Latest Posts
News and Trends 9 Apr 2025
The biotech job market in 2025: Still in survival mode?
The biotech job market has been tough the last few years but is it getting better? Delve into the industry’s job market in 2025.
In Depth 9 Apr 2025
Cystic fibrosis: is the next blockbuster a gene therapy?
Learn about the biotechs progressing their gene therapies for cystic fibrosis and why it might just be the breakthrough that patients need.
Best in Biotech 8 Apr 2025
13 anti-aging startups on a mission to extend lives
Check out 13 anti-aging biotech startups looking to use longevity techniques to extend lives by halting or slowing the aging process.
In Depth 7 Apr 2025
Will tRNA therapy be the next big thing in genetic disease treatment?
Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment.
Podcast 4 Apr 2025
Meeting the global demand for cell therapies: scaling with smart manufacturing
Listen to our talk with Fabian Gerlinghaus CEO of Cellares, about scaling up cell therapies manufacturing.
ADVERTISEMENT
ADVERTISEMENT
News and Trends 4 Apr 2025
Developing drugs from outer space: Exobiosphere raises €2 million
Find out about how biotech is done in space through the example of Exobiosphere and its €2 million seed round.
News and Trends 2 Apr 2025
Top biotech deals of March 2025
Learn about the top biotech deals of March 2025. Small molecules, bispecific antibodies, and protein therapies were all part of major collaborations.
In Depth 2 Apr 2025
Beyond amyloid: The search for the next big thing in Alzheimer’s treatment
Delve into how the biotech industry is pivoting from the amyloid hypothesis to find new Alzheimer’s disease treatments.
In Depth 1 Apr 2025
The biggest biotech funding rounds in March 2025
The companies Isomorphic Labs, DBV Technologies, and Genfit bagged the biggest biotech funding rounds overall in March 2025.
News and Trends 31 Mar 2025
AstraZeneca bets on Asia: a surge of deals in March amid fraud probe
AstraZeneca has vowed to spend over $10 billion in Asia, particularly in China, to build Beijing into an R&D hub amid probe into fraud scandals.
Podcast 28 Mar 2025
Treating spinal cord injuries with stem cells
Listen to our talk with Brian Culley, CEO of Lineage Cell Therapeutics, about the potential of stem cells in spinal cord injuries
ADVERTISEMENT
